TREM2 and non-small cell lung carcinoma: Accumulating scRNA-seq studies have identified several representative subsets of TAMs in NSCLC, defined by the symbolic markers complement 1 q (C1Q), SPP1, triggering receptor expressed on myeloid cells-2 (TREM2), NLRP3, LYVE1 (48–52).